2389988-43-4
2389988-43-4
Chemical Structure
7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine
- CAS No.: 2389988-43-4
- Formula:C12H17N5O6
- Molecular Weight:327.29
IUPAC Name: 2-amino-9-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-7-ethyl-7,9-dihydro-3H-purine-6,8-dione
InChIKey: ZEGPMVJWAGPKJX-GAWUUDPSSA-N
SMILES: OC[C@@H]1[C@H](O)[C@@H](O)[C@H](N2C(N(CC)C3=C2NC(N)=NC3=O)=O)O1
Biological Activity: 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine | 7-Ethyl-7,8-dihydro-8-oxo-9-(β-D-xylofuranosyl)guanine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
